XM does not provide services to residents of the United States of America.
I
I

Imerys

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Syensqo dips to 3-month low on read-across from European peers

BUZZ-Syensqo dips to 3-month low on read-across from European peers ** Shares of Belgian chemicals company Syensqo SYENS.BR fall to the lowest price since March 20 at 83.57 euros ($89.50)on read-across from peers in the Netherlands and France ** "People are making a read-across from Arkema AKE.PA and Akzo Nobel AKZO.AS giving weaker messaging last
A
A
B
I
A

Eiffage, Quilter, Ricardo

EUROPE RESEARCH ROUNDUP-Eiffage, Quilter, Ricardo June 3 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Eiffage, Quilter and Ricardo, on Monday. HIGHLIGHTS * Acciona Energia ANE.MC : Morgan Stanley raises to equalweight from underweight * Eiffage FOUG.PA : Goldman Sachs raises to buy from neutral * Quilter Plc QLT.L : JP Morgan raises to overweight from neutral * Ricardo Plc RCDO.L : Berenberg raises to buy from hold * St.
B
C
C
E
H
H
I
I
J
P
P
R
S
V
D
L
N

Imerys jumps as Q1 marks start of long-awaited recovery

BUZZ-Imerys jumps as Q1 marks start of long-awaited recovery ** Shares in Imerys IMTP.PA rise 10.7% after the French minerals group reported better-than-expected EBITDA in a quarter where it reached its lowest business point, according to co's CEO ** Imerys' Q1 adjusted EBITDA rises 9.2% to 188 million euros ($201 million), 13% above the consensus,
I

French and Benelux stocks-Factors to watch

French and Benelux stocks-Factors to watch May 2 (Reuters) - Below are company-related news and stories from France and Benelux which could have an impact on the region's markets or individual stocks. Worldline WLN.PA : French payment company Worldline on Thursday reported better-than-expected organic growth in first-quarter revenue, driven by its merchant services division.
B
C
C
D
I
T
F
N
U

Imerys Q1 Adjusted EBITDA Up At Eur 188 Million (+9% Versus Last Year)

BRIEF-Imerys Q1 Adjusted EBITDA Up At Eur 188 Million (+9% Versus Last Year) April 30 (Reuters) - Imerys SA IMTP.PA : Q1 ADJUSTED EBITDA AT €188 MILLION (+9% VERSUS LAST YEAR) FIRST QUARTER REVENUE AT €926 MILLION, EXCEEDING BOTH Q3 AND Q4 2023 LEVELS Q1 REVENUE DOWN 7.1% YOY Q1 NET INCOME GROUP SHARE EUR 69 MILLION VERSUS EUR 101 MILLION YEAR
I

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.